Indrayani Biotech

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue14.3129.0715.2517.2525.63
Expenses13.3826.6113.6615.1923.27
EBITDA0.932.461.592.062.36
EBIT0.822.251.321.881.70
Profit Before Tax0.621.661.151.651.79
Net Profit0.621.661.151.651.79
Financial Ratios
Operating Profit Margin6.50%8.46%10.43%11.94%9.21%
Net Profit Margin4.33%5.71%7.54%9.57%6.98%
Earning Per Share (Diluted)0.180.490.340.480.52
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.4.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI